More recently, scientists have given other cannabinoids like CBN (cannabinol) more attention, due to their huge healing potential. This compound was first isolated in the 1930’s by a British chemist. CBN studies have demonstrated its ability to sedate, drive appetite, and bone and skin regeneration. Read on to learn more! Continue reading “CBN (cannabinol) – Cannabinoid Review”
The week of 4/20, 2018 was legitimately jam-packed with exciting news for the medical and recreational cannabis world both locally and internationally.
United Greeneries Ltd is an ACMPR licensed producer of medical cannabis. Its main business activity is the cultivation and sale of medical cannabis in British Columbia and Canada as a whole. The Company received its authorization to cultivate medical cannabis in June 2016 from Health Canada. Continue reading “United Greeneries – Company Overview”
Tetra Bio-Pharma’s main business activity is the research, discovery, and development of medicine and health products based on plants containing natural medicinal qualities, with a particular emphasis on cannabis. The company is currently working with Aphria, one of the leading licensed producers in Canada. Continue reading “Tetra Bio-Pharma – Company Overview”
This week, the cannabis industry made massive strides internationally both symbolically and literally. The first shipment of medical marijuana from Canada to Italy was successful and the American government showed signs of being pretty hands-off when it comes to the cannabis industry. Let’s get right to it. Continue reading “Weekly Roundup: Aurora ships to Italy, Licensed Producer count jumps to 101, Quebec finalizes supply agreement, and more!”
Up Cannabis is an Ontario-based licensed producer of medical marijuana. The producer is licensed to grow and sell dried marijuana and to produce cannabis oil. The Company was granted a second site license on March 29, 2018. The Company is part of Newstrike, a publicly traded cannabis portfolio company. Continue reading “Up Cannabis – Company Overview”
Cannabigerol, also known as CBG, is one of the cannabinoids found in the cannabis plant and was discovered in 1965 by scientists as a constituent of hashish. CBG exists as a cannabigerolic acid in the cannabis plant and is, in fact, one of the first cannabinoids to form in a young marijuana plant. Continue reading “CBG (Cannabigerol) – Cannabinoid Review”
This week was certainly no walk in the park for cannabis stocks, but the cannabis industry still saw some major developments. These developments include MediPharm receiving its cannabis oil production license from Health Canada, a supply agreement between CanniMed and Pharmasave, Cannabis Wheaton acquiring Dosecannn, and the launch of Tilray’s High Park and MedReleaf’s Alta Vie; two very exciting new adult-use recreational market brands. Continue reading “Weekly Roundup: MediPharm granted oil production license, CanniMed to supply Pharmasave, and more!”
Delta 9 Cannabis (Delta) was founded in 2012. In May 2017, Delta 9 entered into an amalgamation agreement with SVT Capital Corp., as part of the process of becoming a public traded company. The company obtained a cannabis production license in December 2013 under the Marihuana for Medical Purposes Regulations. Delta 9 Cannabis’ main facilities are about 80,000 square feet, located in Osborne Village, East Winnipeg, Manitoba, as well as the company’s headquarters. Continue reading “Delta 9 Cannabis – Company Overview”
With medical cannabis on the rise and recreational market just months away, cannabis research is accelerating faster than ever. Interestingly, scientists and medical professionals haven’t uncovered a standard daily dosage. Further, the equivalency factor from dried cannabis to other forms (oils, for example) is still not defined or fully backed by research. This short article will shed some light on the recommended dosage by Health Canada based on recent clinical research and community expertise.